The prediction of BCR, a highly significant marker for assessing the progression to mortality in patients with PCa, has consistently been a primary objective for clinicians engaged in PCa research.[ 15 ] AI has various uses in patients with PCa.
← all excerpts
Artificial intelligence in prostate cancer: The potential of machine learning models and neural networks to predict biochemical recurrence after robot-assisted radical prostatectomy.
1
—
—